Navigation Links
Catalyst Pharmaceutical Partners Continues Clinical Development of CPP-109 For The Treatment of Cocaine and Methamphetamine Addiction
Date:9/30/2009

atalystpharma.com.

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ materially from forecasted results. A number of factors, including the Company's ability to successfully obtain the financing required to perform future clinical trials of CPP-109 evaluating its use in the treatment of cocaine addiction and methamphetamine addiction, the Company's ability to successfully complete such future clinical trials that it determines to undertake, the Company's ability to successfully conduct such additional number of trials as may be required to file an NDA for CPP-109, and those other factors described in the Company's filings with the U.S. Securities and Exchange Commission (SEC), could adversely affect the Company. Copies of the Company's filings with the SEC are available from the SEC, may be found on the Company's website or may be obtained upon request from the Company. The Company does not undertake any obligation to update the information contained herein, which speaks only as of this date.

SOURCE Catalyst Pharmaceutical Partners


'/>"/>
SOURCE Catalyst Pharmaceutical Partners
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
2. Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
3. Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
4. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
5. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
6. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
7. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
8. Sagent Pharmaceuticals Launches Vinorelbine Injection, USP
9. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
10. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
11. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals International, ... (the "Company") announced today that VPII Escrow Corp., a ... has launched its offer of approximately $3.2 billion aggregate ... Notes will be due in 2021 and in 2023, ... Company intends to use the net proceeds from the ...
(Date:6/18/2013)... June 18, 2013  Actavis, Inc. (NYSE: ACT ... with the U.S. Securities and Exchange Commission (SEC) a registration ... of Warner Chilcott plc (NASDAQ: WCRX ... Warner Chilcott (the "Form S-4"). As ... Chilcott have entered into a definitive agreement pursuant to ...
(Date:6/18/2013)... CITY, N.Y. , June 18, 2013 /PRNewswire/ ... that it has entered into an exclusive 25-year ... Mid-Atlantic regions with eWellness Corporation ("EWC") for its ... "An easy to use physical therapy program is ... diabetes and cardiovascular disease," said Chris Amandola ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3
... , - Research Collaboration ... Jubilant Organosys Ltd, headquartered ... subsidiary,Jubilant Biosys Ltd, has signed a research,collaboration agreement ... into the international pharmaceutical company,s pre-clinical,pipeline. Under the ...
... EPSScentral LLC today announced its readiness to assist ... the face of WHO,s phase 5 classification of the ... 5 "... is a strong signal that a pandemic ... measures is short." (Logo: http://www.newscom.com/cgi-bin/prnh/20080701/DC26612LOGO ...
Cached Medicine Technology:Jubilant Enters Research Collaboration With AstraZeneca 2Jubilant Enters Research Collaboration With AstraZeneca 3Jubilant Enters Research Collaboration With AstraZeneca 4EPSScentral Responds to Pandemic Alert 2
(Date:6/19/2013)... 19, 2013 MinuteHound, a leading time ... can save businesses up to 8% on payroll costs. ... traditional time card systems. Their biometric system is simple: ... which clocks them in and out automatically. Employee ... theft and buddy punching. , Because the fingerprint ...
(Date:6/19/2013)... June 19, 2013 Faith4Kidz is starting a ... equals Peace". Faith4Kidz would like help showing support for kids ... that are more positive. Check out the website, http://www.gracenfaith.com ... The logo is red, white and blue stars as a ... independence throughout history as well as the stars we should ...
(Date:6/18/2013)... 18, 2013 As a sponsor of the 2013 Fourth ... team at Lake Meridian Chiropractic want you to get out and celebrate! ... of the event and are excited to be involved. “My husband ... We've always loved going to the Kent Splash event. It's a ... made sense to financially support this fun day.” , ...
(Date:6/18/2013)... 19, 2013 Parker Waichman LLP, a ... victims injured by dangerous drugs and medical devices, has ... who alleges that she was injured by transvaginal ... 30th in the U.S. District Court for the Southern ... the multidistrict litigation entitled In Re: American Medical Systems, ...
(Date:6/18/2013)... Daily Gossip Magazine has always kept its ... articles. , The magazine has decided to prepare readers ... new anabolic recipe every week . , According to ... guide for readers who are looking to get insights into ... reveals that anabolic food is almost entirely based on healthy, ...
Breaking Medicine News(10 mins):Health News:MinuteHound Announces How Cloud Computing Technology Boosts Savings 2Health News:MinuteHound Announces How Cloud Computing Technology Boosts Savings 3Health News:Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission 2Health News:Lake Meridian Chiropractic of Kent, WA to Sponsor the Fireworks Finale at 15th Annual Fourth of July Splash 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2
... 11 MedImmune, the,global biologics unit of AstraZeneca, ... Holdings, Inc., announced today that they have entered,into ... commercialize,SBI Biotech,s anti-ILT7 protein for the potential treatment ... MedImmune has,global rights to any resulting product candidates ...
... back,to school, parents gain flexibility in what their ... Department of Agriculture (USDA),announced parents or legal guardians ... cow,s milk for children receiving National School Lunch ... growing diversity of,participants in the School Nutrition Programs ...
... Sept. 11 /Xinhua-PRNewswire-FirstCall/ -- Genesis,Pharmaceuticals Enterprises, Inc. (OTC ... pharmaceutical company in the People,s Republic,of China, today ... a,total value of approximately $12 million over the ... the 43rd Annual New Drugs Conference (the,"Conference") sponsored ...
... MIT study suggests , , THURSDAY, Sept. 11 (HealthDay News) -- ... your eyes. , A team of neuroscientists publishing ... they have tricked the brain into confusing one object the ... humans to learn to recognize objects. , People never really ...
... waiting room time more enjoyable and informative for patients, ... and helping doctors become more profitable in the process. ... is Ear, Nose & Throat Associates of South Florida ... month in Chicago at AOA-26 and OTO EXPO and ...
... NBTY, Inc. (NYSE:,NTY) (http://www.NBTY.com ), a leading global ... will web cast the,presentation by Harvey Kamil, President and ... Ideas Conference in New York on Wednesday,September 17, 2008., ... live on NBTY,s web site, (http://www.nbty.com ) on Wednesday, ...
Cached Medicine News:Health News:MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech 2Health News:Parents Can Now Ask Schools to Serve Soymilk 2Health News:Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million 2Health News:Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million 3Health News:Time Teaches Brain to Recognize Objects 2Health News:Mediplay Makes Marketing More Profitable For Physicians 2Health News:Mediplay Makes Marketing More Profitable For Physicians 3Health News:NBTY to Web Cast Presentation at CL King Best Ideas Conference 2
Combination heat and moisture exchanger and bacterial/viral filters for Anesthesia and Respiratory applications....
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
HME w/bacterial viral filter w/CO2...
Indications For Usage: ,Infant (recommended tidal volume 20-70ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended ...
Medicine Products: